Therapeutic Asset Ratings
502 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Volrustomig
Ovarian Cancer
AstraZeneca
P2
CC
(46)
azd7503
NASH
AstraZeneca
P1
CC
(46)
azd7503
Metabolic Dysfunction-Associated Steatohepatitis
AstraZeneca
P1
CC
(46)
azd9550
Metabolic Dysfunction-Associated Steatohepatitis
AstraZeneca
P1
CC
(46)
Calcium folinate pentahydrate
Advanced Solid Tumours
AstraZeneca
P1
CC
(46)
Irinotecan
Advanced Solid Tumours
AstraZeneca
P1
CC
(46)
Medi0618
Chronic Pain Syndrome
AstraZeneca
P1
CC
(46)
[11C]AZ1419 3391
Advanced Solid Malignancies
AstraZeneca
P1/2
CC
(45)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Lung Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Solid Tumours
AstraZeneca
P1/2
CC
(45)
azd4512
B-Cell Non-Hodgkin Lymphoma
AstraZeneca
P1/2
CC
(45)
azd4956
Solid Tumours
AstraZeneca
P1/2
CC
(45)
azd5305
Lung Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
azd5305
Solid Tumours
AstraZeneca
P1/2
CC
(45)
azd5492
B-Cell Neoplasm
AstraZeneca
P1/2
CC
(45)
azd6750
Cutaneous Neuroendocrine Carcinoma
AstraZeneca
P1/2
CC
(45)
azd8421
Ovarian Serous Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
Camizestrant
Ovarian Serous Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
Datopotamab Deruxtecan
Advanced Solid Malignancies
AstraZeneca
P1/2
CC
(45)
Durvalumab
Childhood Malignant Neoplasm
AstraZeneca
P1/2
CC
(45)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Childhood Malignant Neoplasm
AstraZeneca
P1/2
CC
(45)
LEUPROLIDE
High-grade Serous Ovarian Cancer (HGSOC)
AstraZeneca
P1/2
CC
(45)
Palacaparib
Advanced Solid Malignancies
AstraZeneca
P1/2
CC
(45)
Palacaparib
Lung Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
Ribociclib
Ovarian Serous Adenocarcinoma
AstraZeneca
P1/2
CC
(45)
Showing 251 to 275 of 502 assets
Previous
Page 11 of 21
Next